The Role of Rituximab in Primary Central Nervous System Lymphoma (Pcnsl): A Systematic Review and Meta-Analysis

Hematological Oncology - United Kingdom
doi 10.1002/hon.136_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Primary Central Nervous System Lymphoma

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2018English

Primary Central Nervous System Lymphoma

Contemporary Neurosurgery
2010English

Primary Central Nervous System Lymphoma

Journal of Neurosurgery
SurgeryNeurology
1985English

Prognostic Significance of Interim 11 C-Methionine PET for the Treatment of Primary Central Nervous System Lymphoma (PCNSL)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Primary Central Nervous System Lymphoma: A Curable Disease

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Treatment of Central Nervous System Lymphoma in Rats With Intraventricular Rituximab and Serum

International Journal of Hematology
Hematology
2010English

Neurolymphomatosis Appeared Following Primary Central Nervous System Lymphoma

Internal Medicine
Internal MedicineMedicine
2017English

Primary Central Nervous System Lymphoma: A Diagnostic and Therapeutic Challenge-Case Report and Short Review

Open access Journal of Neurology & Neurosurgery
2017English

Primary Central Nervous System Lymphoma: Coming or Going?

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy